Case Report: Targeting of individual somatic tumor mutations by multipeptide vaccination tailored for HLA class I and II presentation induces strong CD4 and CD8 T-cell responses in a patient with metastatic castration sensitive prostate cancer

By sjmartinez • November 3, 2023

Zelba H, Rabsteyn A, Bartsch O, Kyzirakos C, Kayser S, Seibold M, Harter J, Latzer P, Hadaschik D, Battke F, Golf A, Rettig MB, Biskup S. Case Report: Targeting of individual somatic tumor mutations by multipeptide vaccination tailored for HLA class I and II presentation induces strong CD4 and CD8 T-cell responses in a patient with metastatic castration sensitive prostate cancer. Front Immunol. 2023 Oct 18;14:1271449. doi: 10.3389/fimmu.2023.1271449. PMID: 37920460; PMCID: PMC10619716.

Tags: APC, Cardiology/Epi, Harbor UCLA, neoantigen, peptide, prostate cancer, Publications, Vaccination

Systems genetics uncovers associations among host amylase locus, gut microbiome, and metabolic traits in mice

Zhang Q, Hutchison ER, Pan C, Warren MF, Keller MP, Attie AD, Lusis AJ, Rey FE. Systems genetics uncovers associations among host amylase locus, gut[...]

Do Pulmonary Embolism Response Teams in Acute Pulmonary Embolism Improve Outcomes? Insights from a Meta-analysis

Maqsood MH, Zhang RS, Rosenfeld K, Moriarty JM, Rosovsky RP, Horowitz JM, Alviar CL, Bangalore S. Do Pulmonary Embolism Response Teams in Acute Pulmonary Embolism[...]

Rethinking early anticoagulation in bioprosthetic valve surgery

Ghantous E. Rethinking early anticoagulation in bioprosthetic valve surgery. Int J Cardiol. 2025 Apr 18:133289. doi: 10.1016/j.ijcard.2025.133289. Epub ahead of print. PMID: 40254144.